The earnings model of the pharmaceutical industry needs to be overhauled
Posted in category:
Opinion
Published on:
This article was published on 28 April 2020 in Dutch on the website of Follow the money(opens in new window)
The pharmaceutical industry – essential in the pandemic – did not invest enough in medicines such as coronavirus inhibitors, but allowed itself to be emptied like an ATM by shareholders. The high profit margins on medicines, possibly partly due to publicly funded research, are also detrimental to society. Big Pharma urgently needs a restart.
Read more on Follow the money(opens in new window)
Do you need more information?
-
Rodrigo Fernandez
Senior researcher
Related news
-
EU health data law rolls out the red carpet for Big TechPosted in category:Long read
Irene SchipperPublished on: -
Civil society coalition urges EU to put the interests of patients and citizens at the heart of the European Health Data SpacePosted in category:Published on:Statement
-
